UK
UK Nutrigenomics Market Industry Trends and Forecast to 2034: Segmented by (Product, Channel, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
UK · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Germany at $27.2 Mn.
Italy at 14.9% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$45.1 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $19.7 Mn | — | — |
| 2025 (base) | $22.3 Mn | +$2.6 Mn | — |
| 2026 (forecast) | $25.2 Mn | +$2.9 Mn | +13.1% |
| 2027 (forecast) | $28.5 Mn | +$3.3 Mn | +27.9% |
| 2028 (forecast) | $32.2 Mn | +$3.7 Mn | +44.7% |
| 2029 (forecast) | $36.4 Mn | +$4.2 Mn | +63.6% |
| 2030 (forecast) | $41.2 Mn | +$4.8 Mn | +85.1% |
| 2031 (forecast) | $46.6 Mn | +$5.4 Mn | +109.3% |
| 2032 (forecast) | $52.7 Mn | +$6.1 Mn | +136.7% |
| 2033 (forecast) | $59.6 Mn | +$6.9 Mn | +167.7% |
| 2034 (forecast) | $67.4 Mn | +$7.8 Mn | +202.8% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US
$361.0 Mn
Canada
$70.6 Mn
China
$65.5 Mn
Japan
$43.5 Mn
Germany
$27.2 Mn
UK (this report)
$22.3 Mn
Brazil
$21.4 Mn
France
$18.7 Mn
Italy
$18.0 Mn
Ecuador
$15.5 Mn
India
$16.0 Mn
Saudi Arabia
$14.2 Mn
Mexico
$13.6 Mn
Spain
$13.2 Mn
Australia
$10.5 Mn
Russia
$8.8 Mn
New Zealand
$7.8 Mn
South Africa
$5.2 Mn
UAE
$3.9 Mn
Egypt
$2.0 Mn
Philippines
$2.0 Mn
Hong Kong
$1.4 Mn
Malaysia
$1.3 Mn
Thailand
$0.9 Mn
Singapore
$0.8 Mn
Kenya
$0.5 Mn
Nutrigenomics uses genetic tests to give personal diet and nutrition advice based on how genes affect the body's use of food.
Key segments of the nutrigenomics market include product (DNA Diet Tests, Personalized Supplements and Coaching Services) and channel (Online, Clinics and Fitness Centers).
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the nutrigenomics market.
Routine use of genomics in screening, pharmacy and primary care gives the nutrigenomics market large room to grow.
Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the nutrigenomics market.
The nutrigenomics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Food and supplement rules, labelling and health-claim regulations govern nutrigenomics products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in UK.
What doctors and scientists are doing in Nutrigenomics right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
UK · 1 shared keyword
UK · 1 shared keyword
UK · 1 shared keyword
UK · 1 shared keyword
UK · 1 shared keyword
UK
Pharmaceuticals · UK
Digital Health · UK
Healthcare Services · UK
Healthcare Services · UK
Medical Devices · UK
Digital Health · UK